Advertisement

Acute Treatment of Alcohol and Cocaine Emergencies

  • Wanda A. Taylor
  • Andrew E. Slaby
Part of the Recent Developments in Alcoholism book series (RDIA, volume 10)

Abstract

This chapter addresses the acute treatment of alcohol and cocaine. Because of the widespread use of both these drugs, health professionals must recognize the medical complications of alcohol and cocaine abuse and addiction. The biochemistry will be briefly reviewed as an avenue to understand the different treatment targets and modalities.

Keywords

Alcohol Withdrawal Thiamine Deficiency Fetal Alcohol Syndrome Cocaine Abuse Cocaine Dependence 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Johanson C-E, Fischman MW: The pharmacology of cocaine related to its abuse. Pharmacol Rev 41(1):3–52, 1989.PubMedGoogle Scholar
  2. 2.
    Frisshman WH, Karpenos A, Molloy TJ: Cocaine-induced coronary artery disease. Med Clin North Am 73(2):475–486, 1989.Google Scholar
  3. 3.
    Taylor WA, Gold MS: Pharmacologic approaches to the treatment of cocaine dependence. West J Med 152:573–577, 1990.PubMedGoogle Scholar
  4. 4.
    Dackis CA, Gold MS: The new concept in cocaine addiction: the dopamine depletion hypothesis. Neurosci Biobehav Rev 9:469–477, 1985.PubMedCrossRefGoogle Scholar
  5. 5.
    Garder EL: Brain reward, drug addiction relationship. Psychiatr Times, pp 12-16, Oct 1989.Google Scholar
  6. 6.
    Dackis CA, Gold MS: Psychopharmacology of cocaine. Psychiatr Ann 18:528–530, 1988.Google Scholar
  7. 7.
    Giannini AJ, Folts DJ, Feather JN, et al.: Bromocriptine and amantadine in cocaine detoxification. Psychiatr Res 29:11–16, 1989.CrossRefGoogle Scholar
  8. 8.
    Hall WC, Talbert RL, Ereshefsky L: Cocaine abuse and its treatment. Pharmacotherapy 10(1):47–65, 1990.PubMedGoogle Scholar
  9. 9.
    Gawin FH: Chronic neuropharmacology of cocaine: progress in pharmacotherapy. J Clin Psychiatry (Suppl)48:11–16, 1988.Google Scholar
  10. 10.
    Cunningham KA, Lakoski JM: The interactions of cocaine with serotonin dorsal raphe neurons. Neuropsychopharmacology 3(1):41–50, 1990.PubMedGoogle Scholar
  11. 11.
    Galizio M, Maisto SA: Determinants of Substance Abuse. New York, Plenum Press, 1985.CrossRefGoogle Scholar
  12. 12.
    Mendelson JH, Mello NK: The Diagnosis and Treatment of Alcoholism, ed 2. New York, McGraw-Hill, 1985.Google Scholar
  13. 13.
    Miller NS, Gold MS, Cocores JA, Pottash AC: Alcohol dependence and its medical consequences. NY State J Med 88(9):476–481, 1988.Google Scholar
  14. 14.
    Dackis CA, Gold MS, Estroff TW: Inpatient treatment of addiction, in Karasu TB (ed): Treatment of Psychiatric Disorders—A Task Force Report of the American Psychiatric Association, Vol 2. Washington DC, American Psychiatric Press, 1989, pp 1359–1379.Google Scholar
  15. 15.
    Cohen S: Reinforcement and Rapid Delivery Systems: Understanding Adverse Consequences of Cocaine. Cocaine Use in America: Epidemiologic and Clinical Perspectives, Research Monograph 61. Rockville, MD, National Institute on Drug Abuse, 1985.Google Scholar
  16. 16.
    Jones RT: The Pharmacology of Cocaine. Cocaine: Pharmacology, Effects and Treatment of Abuse, Research Monograph 50. Rockville, MD, National Institute on Drug Abuse, 1984.Google Scholar
  17. 17.
    Schweitzer VG: Osteolytic sinusitis and pneumomediastinum: deceptive otolaryngologic complications of cocaine abuse. Laryngoscope 96:206–210, 1986.PubMedGoogle Scholar
  18. 18.
    Vilensky W: Illicit and licit drugs causing perforation of the nasal septum. J Forensic Sci 27:958–962, 1982.PubMedGoogle Scholar
  19. 19.
    Patel RC, Dutta D, Schonfeld SA: Free-base cocaine use associated with bronchiolitis obliterans organizing pneumonia. Ann Intern Med 107(2):a186–187, 1987.CrossRefGoogle Scholar
  20. 20.
    Rebhun J: Association of asthma and freebase smoking. Ann Allergy 60(4):339–342, 1988.PubMedGoogle Scholar
  21. 21.
    Kissner DG, Lawrence WD, Selis JE: Crack lung: pulmonary disease caused by cocaine abuse. Am Rev Respir Dis 136:1250–1252, 1987.PubMedCrossRefGoogle Scholar
  22. 22.
    Morris JB, Shuck, JM: Pneumomediastinum in a young male cocaine user. Ann Emerg Med 14:194–195, 1985.PubMedCrossRefGoogle Scholar
  23. 23.
    Adrouny A, Magnusson P: Pneumopericardium from cocaine inhalation. N Engl J Med 313:48–49, 1985.PubMedGoogle Scholar
  24. 24.
    Weiner MD, Putman CE: Pain in the chest in a user of cocaine. JAMA 258(15):2087–2088, 1987.CrossRefGoogle Scholar
  25. 25.
    Luque MA III, Cavallaro DL, Torres M, et al.: Pneumomediastinum, pneumothorax, and subcutaneous emphysema after alternate cocaine inhalation and marijuana smoking. Pediatr Emerg Care 3(2):107–109, 1987.PubMedCrossRefGoogle Scholar
  26. 26.
    Mittleman RE, Wetli CV: Death caused by recreational cocaine use: an update. JAMA 252:1889–1984, 1984.PubMedCrossRefGoogle Scholar
  27. 27.
    Bozarth MA, Wise RA: Toxicity associated with long-term intravenous heroin and cocaine self-administration in the rat. JAMA 254:81–83, 1985.PubMedCrossRefGoogle Scholar
  28. 28.
    Cregler LL, Herbert M: Medical complications of cocaine abuse. N Engl J Med 315:1495–1500, 1986.PubMedCrossRefGoogle Scholar
  29. 29.
    Shannon M: Clinical toxicity of cocaine adulterants. Ann Emerg Med 17:1243–1247, 1988.PubMedCrossRefGoogle Scholar
  30. 30.
    Heng MCY, Haberfeld G: Thrombotic phenomena associated with intravenous cocaine. J Am Acad Dermatol 16:462–468, 1987.PubMedCrossRefGoogle Scholar
  31. 31.
    Townsend RR, Laing FC, Jeffrey RB: Placental abruption associated with cocaine abuse. Am J Roengenol 150(6):1339–1340, 1988.CrossRefGoogle Scholar
  32. 32.
    Hadeed AJ, Siegel S: Maternal cocaine use during pregnancy: effects on the newborn infant. Pediatrics 84:205–210, 1989.PubMedGoogle Scholar
  33. 33.
    Zuckerman B, Frank DA, MacGregor S, et al.: Effects of maternal marijuana and cocaine use on fetal growth. N Engl J Med 320:762–768, 1989.PubMedCrossRefGoogle Scholar
  34. 34.
    MacGregor SN, Keith LQ, Chasnoff IJ, et al.: Cocaine use during pregnancy: adverse perinatal outcome. Am J Obstet Gynecol 157:686–690, 1987.PubMedGoogle Scholar
  35. 35.
    Acker D, Sachs BJ, Iracey KJ, Wise WE: Abruptio placentae associated with cocaine use. Am J Obstet Gynecol 146:220–221, 1983.PubMedGoogle Scholar
  36. 36.
    Chasnoff IJ, Griffith DR, MacGregor S, et al.: Temporal patterns of cocaine use in pregnancy. JAMA 261:1741–1744, 1989.PubMedCrossRefGoogle Scholar
  37. 37.
    Woods, JR, Plessinger MA, Clark KE: Effect of cocaine on uterine blood flow and fetal oxygenation. JAMA 257:957–961, 1987.PubMedCrossRefGoogle Scholar
  38. 38.
    Doberczak TM, Shanzer S, Senie RT, Kendall SR: Neonatal neurologic and electroencephalographic effects of intrauterine cocaine exposure. J Pediatr 113:354–358, 1988.PubMedCrossRefGoogle Scholar
  39. 39.
    Nademanee K, Gorelick DA, Josephson MA, et al.: Myocardial ischemia during cocaine withdrawal. Ann Intern Med 111:876–880, 1989.PubMedCrossRefGoogle Scholar
  40. 40.
    Karch SB: The history of cocaine toxicity. Hum Pathol 20:1037–1039, 1989.PubMedCrossRefGoogle Scholar
  41. 41.
    Karch SB, Billingham ME: The pathology and etiology of cocaine-induced heart disease. Arch Pathol Lab Med 112:225–230, 1988.PubMedGoogle Scholar
  42. 42.
    Virmani R, Robinowitz M, Smialek JE, et al.: Cardiovascular effects of cocaine: an autopsy study of 40 patients. Am Heart J 115:1068–1076, 1988.PubMedCrossRefGoogle Scholar
  43. 43.
    Fishbain DA, Wetli CV: Cocaine intoxication, delirium, and death in a body packer. Ann Emerg Med 10:531–532, 1981.PubMedCrossRefGoogle Scholar
  44. 44.
    Introna F Jr, Smialek JE: The “Mini-Packer” syndrome. Am J Forensic Med Pathol 10:21–24, 1989.PubMedCrossRefGoogle Scholar
  45. 45.
    Levine SR, Washington JM, Jefferson MF, et al.: “Crack” cocaine-associated stroke. Neurology 37:1849–1853, 1987.PubMedCrossRefGoogle Scholar
  46. 46.
    Lipton RB, Choy-Kwong M, Solomon S: Headaches in the hospitalized cocaine users. Headache 29:224–227, 1989.Google Scholar
  47. 47.
    Mangiardi JR, Geller ME, Weitzner I, Tuchman AJ: Cocaine-related intracranial hemorrhage. Acta Neurol Scand 77:177–180, 1988.PubMedCrossRefGoogle Scholar
  48. 48.
    Lowenstein DH, Massa SM, Rowbotham MC, et al.: Acute neurologic and psychiatric associated with cocaine abuse. Am J Med 83:841–846, 1987.PubMedCrossRefGoogle Scholar
  49. 49.
    Manschreck TC, Allen DF, Neville M: Freebase psychosis: cases from a Bahamian epidemic of cocaine abuse. Comer Psychiatry 28(6):555–564, 1987.CrossRefGoogle Scholar
  50. 50.
    Sherer MA, Kumor KM, Cone EJ, et al.: Suspiciousness induced by four-hour intravenous infusion of cocaine. Arch Gen Psychiatry 45:673–677, 1988.PubMedCrossRefGoogle Scholar
  51. 51.
    Aronson TA, Craig TY: Cocaine precipitation of panic disorder. Am J Psychiatry 143:643–645, 1986.PubMedGoogle Scholar
  52. 52.
    Louie AK, Lannon RA, Ketter TA: Treatment of cocaine-induced panic disorder. Am J Psychiatry 146:40–44, 1989.PubMedGoogle Scholar
  53. 53.
    Washton AM, Gold MS: Chronic cocaine abuse: evidence for adverse effects on health and functioning. Psychiatr Ann 14:733–739, 1984.Google Scholar
  54. 54.
    Cregler LL: Adverse health consequences of cocaine abuse. J Nat Med Assoc 81:27–37, 1989.Google Scholar
  55. 55.
    Mueller PD, Benowitz NL, Olson KR: Cocaine. Emerg Med Clin North Am 8:481–493, 1990.PubMedGoogle Scholar
  56. 56.
    Kosten TR, Kleber HD: Sudden death in cocaine abusers: relation to neuroleptic malignant syndrome. Lancet 1:1198,1987 (letter).PubMedCrossRefGoogle Scholar
  57. 57.
    Loper KA: Clinical toxicology of cocaine. Med Toxicol Adverse Drug Exp 4:174–185, 1989.PubMedCrossRefGoogle Scholar
  58. 58.
    Dackis CA, Gold MS: Bromocriptine as treatment of cocaine abuse. Lancet 1:1151–1152, 1985.PubMedCrossRefGoogle Scholar
  59. 59.
    Dackis CA, Gold MS: Pharmacological approaches to cocaine addiction. J Subst Abuse Treat 2:139–145, 1985.PubMedCrossRefGoogle Scholar
  60. 60.
    Giannini AJ, Baumgartel P, DiMarzio LR: Bromocriptine therapy in cocaine withdrawal. J Clin Pharmacol 27:549–554, 1987.PubMedCrossRefGoogle Scholar
  61. 61.
    Tennant FS, Sagherian AA: Double-blind comparison of amantadine and bromocriptine for ambulatory withdrawal from cocaine dependence. Arch Intern Med 147:109–112, 1987.PubMedCrossRefGoogle Scholar
  62. 62.
    Gold MS, Pottash ALC, Annitto WJ, et al.: Cocaine withdrawal: efficacy of tyrosine. Soc Neurosci Abstr 9:157, 1983.Google Scholar
  63. 63.
    Trachtenberg MC, Blum K: Improvement of cocaine-induced neuromodulator deficits by the neuronutrient tropamine. J Psychoactive Drugs 20:315–331, 1988.PubMedCrossRefGoogle Scholar
  64. 64.
    Charney DS, Menkos DB, Heninger GR: Receptor sensitivity and mechanism of action of antidepressant treatment: implications for the etiology and therapy of depression. Arch Gen Psychiatry 38:1160–1180, 1981.PubMedCrossRefGoogle Scholar
  65. 65.
    Tennant FS, Rawson RA, McCann MA: Withdrawal from chronic phencyclidine (PCP) dependence with desipramine. Am J Psychiatry 138:845–847, 1981.PubMedGoogle Scholar
  66. 66.
    Gawin FH: New uses of antidepressants in cocaine abuse. Psychosomatics 27:s24–s29, 1986.Google Scholar
  67. 67.
    Tennant FS, Tarver AL: Double-blind comparison of desipramine and placebo in withdrawal from cocaine dependence. Natl Inst Drug Abuse Res Monogr Ser 55:159–163, 1984.Google Scholar
  68. 68.
    Gawin FH, Allen D, Humblestone B: Outpatient treatment of “crack” cocaine smoking with flupenthixol decanoate. Arch Gen Psychiatry 46:322–325, 1989.PubMedCrossRefGoogle Scholar
  69. 69.
    Gawin FH, Kleber HD: Cocaine abuse treatment: open pilot trial with desipramine and lithium carbonate. Arch Gen Psychiatry 41:903–909, 1984.PubMedCrossRefGoogle Scholar
  70. 70.
    Khantzian EJ: Methylphenidate (Ritalin) treatment of cocaine dependence—a preliminary report. J Subst Abuse 1:107–112, 1984.CrossRefGoogle Scholar
  71. 71.
    Kosten TR, Kleber HD, Morgan C: Treatment of cocaine abuse with buprenorphine. Biol Psychiatry 26:637–639, 1989.PubMedCrossRefGoogle Scholar
  72. 72.
    Pedersdorf RG, Adams RD, Braunwald E, et al. (eds): Harrison’s Principles of Internal Medicine, ed 10. New York, McGraw-Hill, 1983.Google Scholar
  73. 73.
    Lieber CS: Medical Disorders of Alcoholism. Philadelphia, Saunders, 1982.Google Scholar
  74. 74.
    Grant BF, Dufour MC, Harford TC: Epidemiology of alcoholic liver disease. Semin Liver Dis 8(1)112–25, 1988.CrossRefGoogle Scholar
  75. 75.
    Miller NS, Gold MS, Cocores JA, Pottash AC: Alcohol dependence and its medical consequences. NY State J Med 88(9):476–481, 1988.Google Scholar
  76. 76.
    Schuckit MA: Alcoholism: An Introduction Drug and Alcohol Abuse: A Clinical Guide to Diagnosis and Treatment. New York, Plenum Press, 1989.Google Scholar
  77. 77.
    Lange LG, Kinnunen PM: Cardiovascular effects of alcohol. Adv Alcohol Subst Abuse 6(3):47–51, 1987.PubMedCrossRefGoogle Scholar
  78. 78.
    Criqui MH: Alcohol consumption, blood pressure, lipids, and cardiovascular mortality. Alcohol Clin Exp Res 10:564–569, 1986.PubMedCrossRefGoogle Scholar
  79. 79.
    Beilin LJ: Epidemiology of alcohol and hypertension. Adv Alcohol Subst Abuse 6:69–87, 1987.PubMedCrossRefGoogle Scholar
  80. 80.
    Ballard HS: Hematological complications of alcoholism. Alcohol Clin Exp Res 13(5):706–720, 1989.PubMedCrossRefGoogle Scholar
  81. 81.
    Schenker S, Becker HC, Randell CL, et al.: Fetal alcohol syndrome: current status of pathogenesis. Alcohol Clin Exp Res 14(5):635–647, 1990.PubMedCrossRefGoogle Scholar
  82. 82.
    Nanson JL, Hiscock M: Attention deficits in children exposed to alcohol prenatally Alcohol Clin Exp Res 14(5):656–661, 1990.PubMedCrossRefGoogle Scholar
  83. 83.
    Soderstrom CA, Carson SL: Update: alcohol and other drug use among vehicular crash victims. Maryland Med J 37(7):541–545, 1988.Google Scholar
  84. 84.
    Schuckit MA: Alcoholism and other psychiatric disorders. Hosp Community Psychiatry 34:1022–1027, 1983.PubMedGoogle Scholar
  85. 85.
    Martin RL, Cloninger CR, Guze SB, et al.: Mortality in a follow-up to 500 psychiatric outpatients. I. Total mortality. Arch Gen Psychiatry 42:47–66, 1985.PubMedCrossRefGoogle Scholar
  86. 86.
    Chiang WK, Goldfrank LR: Substance withdrawal. Emerg Med Clin North Am 8(3):613–631, 1990.PubMedGoogle Scholar
  87. 87.
    Charness ME, Simon RP, Greenberg DA: Ethanol and the nervous system. N Engl J Med 321(7):442–454, 1989.PubMedCrossRefGoogle Scholar
  88. 88.
    Little HJ, Dolin SJ, Halsey MJ: Calcium channel antagonists decrease the ethanol withdrawal syndrome. Life Sci 39:2059–2065, 1986.PubMedCrossRefGoogle Scholar
  89. 89.
    Roy A, Pickar D, Linnoila M, et al.: Cerebalspinal fluid corticotropin-releasing hormone in depression: relationship to noradrenergic function. Psychiatr Res 20:229–237, 1987.CrossRefGoogle Scholar
  90. 90.
    Lovinger DM, White G, Weight FF: Ethanol inhibits NMDA-activated ion current in hippocampal neurons. Science 243:1721–1724, 1989.PubMedCrossRefGoogle Scholar
  91. 91.
    Tabakoff B, Hoffmann PL: Biochemical pharmacology of alcohol, in Meltzer HY (ed): Psychopharmacology: The Third Generation of Progress. New York, Raven Press, 1987.Google Scholar

Copyright information

© Springer Science+Business Media New York 1992

Authors and Affiliations

  • Wanda A. Taylor
    • 1
  • Andrew E. Slaby
    • 2
  1. 1.Adolescent Dual Diagnosis UnitFair Oaks HospitalSummitUSA
  2. 2.Fair Oaks HospitalSummitUSA

Personalised recommendations